Annual CFO
$15.81 B
+$4.63 B+41.39%
31 December 2023
Summary:
Novo Nordisk A/S annual cash flow from operations is currently $15.81 billion, with the most recent change of +$4.63 billion (+41.39%) on 31 December 2023. During the last 3 years, it has risen by +$7.85 billion (+98.64%). NVO annual CFO is now at all-time high.NVO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$6.66 B
-$612.55 M-8.42%
30 September 2024
Summary:
Novo Nordisk A/S quarterly cash flow from operations is currently $6.66 billion, with the most recent change of -$612.55 million (-8.42%) on 30 September 2024. Over the past year, it has increased by +$683.05 million (+11.43%). NVO quarterly CFO is now -8.42% below its all-time high of $7.27 billion, reached on 30 June 2024.NVO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$17.32 B
+$683.05 M+4.11%
30 September 2024
Summary:
Novo Nordisk A/S TTM cash flow from operations is currently $17.32 billion, with the most recent change of +$683.05 million (+4.11%) on 30 September 2024. Over the past year, it has increased by +$1.34 billion (+8.41%). NVO TTM CFO is now at all-time high.NVO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.4% | +11.4% | +8.4% |
| 3 y3 years | +98.6% | +102.9% | +91.9% |
| 5 y5 years | +123.7% | +171.9% | +132.0% |
NVO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +98.6% | -8.4% | +1591.6% | at high | +97.9% |
| 5 y | 5 years | at high | +125.4% | -8.4% | +1591.6% | at high | +147.8% |
| alltime | all time | at high | +8403.1% | -8.4% | +1591.6% | at high | +7596.6% |
Novo Nordisk A/S Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.66 B(-8.4%) | $17.32 B(+4.1%) |
| June 2024 | - | $7.27 B(+248.7%) | $16.63 B(+22.3%) |
| Mar 2024 | - | $2.08 B(+60.1%) | $13.60 B(-14.0%) |
| Dec 2023 | $15.81 B(+41.4%) | $1.30 B(-78.2%) | $15.81 B(-1.0%) |
| Sept 2023 | - | $5.98 B(+41.1%) | $15.97 B(+23.7%) |
| June 2023 | - | $4.23 B(-1.5%) | $12.91 B(+8.3%) |
| Mar 2023 | - | $4.30 B(+193.6%) | $11.92 B(+6.6%) |
| Dec 2022 | $11.18 B(+27.8%) | $1.46 B(-49.7%) | $11.18 B(+20.6%) |
| Sept 2022 | - | $2.91 B(-10.4%) | $9.27 B(-3.8%) |
| June 2022 | - | $3.25 B(-8.7%) | $9.64 B(-8.0%) |
| Mar 2022 | - | $3.56 B(-897.1%) | $10.49 B(+19.8%) |
| Dec 2021 | $8.75 B(+9.9%) | -$446.39 M(-113.6%) | $8.75 B(-3.0%) |
| Sept 2021 | - | $3.28 B(-19.8%) | $9.02 B(+2.4%) |
| June 2021 | - | $4.09 B(+124.3%) | $8.82 B(+6.1%) |
| Mar 2021 | - | $1.82 B(-1147.5%) | $8.31 B(+4.4%) |
| Dec 2020 | $7.96 B(+13.5%) | -$174.18 M(-105.7%) | $7.96 B(-11.1%) |
| Sept 2020 | - | $3.07 B(-14.3%) | $8.95 B(+7.5%) |
| June 2020 | - | $3.58 B(+142.4%) | $8.33 B(+19.1%) |
| Mar 2020 | - | $1.48 B(+81.4%) | $6.99 B(-0.4%) |
| Dec 2019 | $7.01 B(-0.7%) | $815.04 M(-66.7%) | $7.01 B(-6.0%) |
| Sept 2019 | - | $2.45 B(+9.1%) | $7.47 B(+11.1%) |
| June 2019 | - | $2.25 B(+49.2%) | $6.72 B(-3.4%) |
| Mar 2019 | - | $1.51 B(+18.9%) | $6.95 B(-1.6%) |
| Dec 2018 | $7.07 B(+12.8%) | $1.27 B(-25.6%) | $7.07 B(+8.5%) |
| Sept 2018 | - | $1.70 B(-31.4%) | $6.52 B(-8.0%) |
| June 2018 | - | $2.48 B(+53.2%) | $7.08 B(+15.1%) |
| Mar 2018 | - | $1.62 B(+126.9%) | $6.15 B(-1.8%) |
| Dec 2017 | $6.27 B(-12.7%) | $713.69 M(-68.5%) | $6.27 B(-12.5%) |
| Sept 2017 | - | $2.27 B(+46.2%) | $7.16 B(+0.4%) |
| June 2017 | - | $1.55 B(-10.5%) | $7.13 B(-8.7%) |
| Mar 2017 | - | $1.73 B(+7.7%) | $7.81 B(+8.7%) |
| Dec 2016 | $7.18 B(+26.1%) | $1.61 B(-28.1%) | $7.18 B(+1.5%) |
| Sept 2016 | - | $2.24 B(+0.3%) | $7.07 B(+6.4%) |
| June 2016 | - | $2.23 B(+101.8%) | $6.65 B(+7.6%) |
| Mar 2016 | - | $1.11 B(-26.4%) | $6.18 B(+8.5%) |
| Dec 2015 | $5.70 B(+0.8%) | $1.50 B(-17.2%) | $5.70 B(+3.4%) |
| Sept 2015 | - | $1.81 B(+3.1%) | $5.51 B(-4.9%) |
| June 2015 | - | $1.76 B(+182.9%) | $5.79 B(+4.8%) |
| Mar 2015 | - | $621.90 M(-52.7%) | $5.53 B(-2.2%) |
| Dec 2014 | $5.65 B(+22.4%) | $1.32 B(-37.3%) | $5.65 B(+6.6%) |
| Sept 2014 | - | $2.10 B(+40.3%) | $5.30 B(+22.0%) |
| June 2014 | - | $1.49 B(+100.0%) | $4.35 B(+5.6%) |
| Mar 2014 | - | $746.96 M(-22.5%) | $4.12 B(-10.9%) |
| Dec 2013 | $4.62 B(+20.4%) | $963.64 M(-15.6%) | $4.62 B(+15.0%) |
| Sept 2013 | - | $1.14 B(-9.6%) | $4.02 B(-3.2%) |
| June 2013 | - | $1.26 B(+1.0%) | $4.15 B(+1.2%) |
| Mar 2013 | - | $1.25 B(+246.5%) | $4.10 B(+6.9%) |
| Dec 2012 | $3.84 B | $361.06 M(-71.7%) | $3.84 B(-8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $1.28 B(+5.0%) | $4.17 B(-3.8%) |
| June 2012 | - | $1.21 B(+23.3%) | $4.33 B(+7.2%) |
| Mar 2012 | - | $985.15 M(+42.0%) | $4.04 B(+1.2%) |
| Dec 2011 | $3.99 B(+14.0%) | $693.76 M(-51.8%) | $3.99 B(-5.9%) |
| Sept 2011 | - | $1.44 B(+55.9%) | $4.24 B(+8.2%) |
| June 2011 | - | $923.02 M(-1.5%) | $3.92 B(+7.3%) |
| Mar 2011 | - | $937.16 M(-0.5%) | $3.65 B(+4.3%) |
| Dec 2010 | $3.50 B(+21.7%) | $942.33 M(-15.6%) | $3.50 B(+10.4%) |
| Sept 2010 | - | $1.12 B(+69.7%) | $3.17 B(+2.8%) |
| June 2010 | - | $657.87 M(-16.4%) | $3.09 B(+5.1%) |
| Mar 2010 | - | $786.73 M(+28.5%) | $2.94 B(+2.1%) |
| Dec 2009 | $2.88 B(+13.3%) | $612.27 M(-40.5%) | $2.88 B(+0.5%) |
| Sept 2009 | - | $1.03 B(+102.1%) | $2.86 B(+13.5%) |
| June 2009 | - | $509.37 M(-29.9%) | $2.52 B(-4.8%) |
| Mar 2009 | - | $726.90 M(+21.8%) | $2.65 B(+4.3%) |
| Dec 2008 | $2.54 B(+38.2%) | $596.86 M(-13.3%) | $2.54 B(+5.9%) |
| Sept 2008 | - | $688.78 M(+8.0%) | $2.40 B(+1.2%) |
| June 2008 | - | $637.83 M(+3.4%) | $2.37 B(+18.1%) |
| Mar 2008 | - | $617.11 M(+35.3%) | $2.01 B(+9.2%) |
| Dec 2007 | $1.84 B(+41.0%) | $456.16 M(-30.9%) | $1.84 B(+29.0%) |
| Sept 2007 | - | $659.79 M(+140.6%) | $1.43 B(+3.6%) |
| June 2007 | - | $274.19 M(-38.9%) | $1.38 B(-2.8%) |
| Mar 2007 | - | $448.42 M(+942.6%) | $1.41 B(+8.5%) |
| Dec 2006 | $1.30 B(-10.3%) | $43.01 M(-93.0%) | $1.30 B(-22.2%) |
| Sept 2006 | - | $610.21 M(+94.8%) | $1.68 B(+10.1%) |
| June 2006 | - | $313.17 M(-7.2%) | $1.52 B(-2.0%) |
| Mar 2006 | - | $337.39 M(-18.7%) | $1.55 B(+6.9%) |
| Dec 2005 | $1.45 B(+13.6%) | $414.94 M(-9.1%) | $1.45 B(+3.4%) |
| Sept 2005 | - | $456.40 M(+32.4%) | $1.41 B(+3.0%) |
| June 2005 | - | $344.65 M(+45.4%) | $1.36 B(+5.7%) |
| Mar 2005 | - | $237.06 M(-35.4%) | $1.29 B(+0.9%) |
| Dec 2004 | $1.28 B(+35.9%) | $367.04 M(-11.8%) | $1.28 B(+40.3%) |
| Sept 2004 | - | $416.08 M(+53.8%) | $911.53 M(+84.0%) |
| June 2004 | - | $270.45 M(+20.2%) | $495.45 M(+120.2%) |
| Mar 2004 | - | $224.99 M | $224.99 M |
| Dec 2003 | $940.61 M(+51.6%) | - | - |
| Dec 2002 | $620.55 M(+19.8%) | - | - |
| Dec 2001 | $518.07 M(-20.6%) | - | - |
| Dec 2000 | $652.20 M(+60.6%) | - | - |
| Dec 1999 | $406.08 M(+11.1%) | - | - |
| Dec 1998 | $365.54 M(-20.5%) | - | - |
| Dec 1997 | $459.82 M(+38.7%) | - | - |
| Dec 1996 | $331.58 M(-26.6%) | - | - |
| Dec 1995 | $451.90 M(+7.7%) | - | - |
| Dec 1994 | $419.67 M(+42.1%) | - | - |
| Dec 1993 | $295.30 M(+33.9%) | - | - |
| Dec 1992 | $220.47 M(+18.6%) | - | - |
| Dec 1991 | $185.96 M(-23.7%) | - | - |
| Dec 1990 | $243.65 M | - | - |
FAQ
- What is Novo Nordisk A/S annual cash flow from operations?
- What is the all time high annual CFO for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual CFO year-on-year change?
- What is Novo Nordisk A/S quarterly cash flow from operations?
- What is the all time high quarterly CFO for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly CFO year-on-year change?
- What is Novo Nordisk A/S TTM cash flow from operations?
- What is the all time high TTM CFO for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM CFO year-on-year change?
What is Novo Nordisk A/S annual cash flow from operations?
The current annual CFO of NVO is $15.81 B
What is the all time high annual CFO for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual cash flow from operations is $15.81 B
What is Novo Nordisk A/S annual CFO year-on-year change?
Over the past year, NVO annual cash flow from operations has changed by +$4.63 B (+41.39%)
What is Novo Nordisk A/S quarterly cash flow from operations?
The current quarterly CFO of NVO is $6.66 B
What is the all time high quarterly CFO for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly cash flow from operations is $7.27 B
What is Novo Nordisk A/S quarterly CFO year-on-year change?
Over the past year, NVO quarterly cash flow from operations has changed by +$683.05 M (+11.43%)
What is Novo Nordisk A/S TTM cash flow from operations?
The current TTM CFO of NVO is $17.32 B
What is the all time high TTM CFO for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM cash flow from operations is $17.32 B
What is Novo Nordisk A/S TTM CFO year-on-year change?
Over the past year, NVO TTM cash flow from operations has changed by +$1.34 B (+8.41%)